China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
The CIRC's new draft regulations are set to change the landscape of investments in Chinese insurance companies中国保监会新发布的《保险公司股权管理办法(征求意见稿)》将改变中国保险公司的投资环境
Six key pieces of legislation that would allow the U.S. to confront China if President Trump decides to up the ante—and risk world economic instability
MNCs managing tax audit risks in China must conduct a complete analysis in response to the new APA rules that set higher submission standards and require greater disclosure
China's Supreme People's Court clarifies the jurisdiction of PRC courts, tightens standards for suspension orders and defines the scope of independent guarantee fraud
A quicktake on how the central bank's latest cash curbs impact outbound deals, offshore loans and overseas payments by individuals and corporates
Companies preparing to comply with the imminent PRC Cybersecurity Law must assess its cross-border data restrictions in a global and regulatory context. Here is what MNCs need to know before the law enters into effect in June
What foreign investors need to know about accessing the $8 trillion onshore interbank bond market
The MIIT's draft cloud regulations confirm foreign investment and data limits and set strict rules for local partnerships
China kicks off a new BEPS era with heavier reporting and compliance burdens for MNCs and their local subsidiaries amid a global crackdown on tax avoidance
